Our Experienced Team of Industry Experts
Darren Obrigkeit, PhD
Dr. Obrigkeit is a serial entrepreneur and medical device leader. He has over 25 years’ experience in medical devices and biomaterials, including founding Angstrom Medica (now RTI Surgical – NASDAQ: RTIX), corporate venture investment management at DSM Biomedical, and growing and managing a large portfolio of medical contract design, manufacturing, and services at Flextronics Medical. He earned his Chemical Engineering PhD from MIT in numerical modeling of complex aerosol and particulate processes.
David Kay, MD
Founder & CMO
With more than 40 years of medical experience, Dr. Kay is a foot and ankle orthopedic surgeon and an industry KOL. As an inventor and entrepreneur, he partners with individuals who are looking to commercialize their product concepts or established companies that need a new direction in product development. Dr. Kay founded Orthohelix in 1995 to develop innovative implants and instruments for use in small bone reconstructive foot and ankle surgery with an exit of $135M in 2012 to Tornier. His work in innovative foot and ankle implants is widely published and he has participated in over 20 medical device product launches. Dr. Kay is a founder of Okapi and brings a wealth of entrepreneurial and operational expertise in addition to a deep network of colleague KOLs.
Founder & Board Member
Mr. Fuller has worked at the intersection of innovation and commercialization for more than 20 years and has started four companies to date – all based in medical technology. He founded Okapi Medical with Dr. Kay in 2017. Before Okapi, he was CEO-in-Residence at BioEnterprise and was Founder and CEO of Centerline Biomedical. Mr. Fuller co-founded S4 Medical with Dr. Daoud in 2017. He has a proven ability to successfully launch and manage new medical technology companies.
Chairman of the Board
Currently serving as the Entrepreneur-in-Residence in the life sciences for GLIDE and Jumpstart, Russ Donda has more than 25 years of executive and startup entrepreneurial experience. He serves on multiple startup boards, is an inventor on a number of patents, and among other startup projects, he was the founding CEO and chairman for ViewRay, a university spinout that developed a novel form of radiation therapy.
ViewRay was subsequently venture funded and is now publicly traded (Nasdaq: VRAY). Mr. Donda was a founding member of, and co-chair of investment review for, the Emergent Growth Fund, LLC (www.emergentgrowth.com), an angel investment fund; he was also a cofounder of, and spearheaded business development for, Regeneration Technologies, a university spinout now publicly traded (Nasdaq: RTIX).
Senior Director of Compliance
Ms. Smith formerly held leadership positions at Adhezion and Ventana Medical Systems. With four 510(k)s in topical skin adhesives and broad regulatory experience ranging from skin adhesive to pharma and diagnostics, she brings unique and highly relevant expertise to Okapi. Ms. Smith holds a Master’s degree in Regulatory Affairs.
Mr. Zhao earned his Master’s degree in Biomedical/Medical Engineering. He has worked with multiple startups and is versed in intellectual property, animal studies, market research, and analysis. At Okapi, Mr. Zhao has been instrumental in market and intellectual property research, product prototypes, and the success of Okapi’s preclinical porcine testing program and product development. He supports company patents by conducting ongoing patent studies, literature reviews, and market research of domestic and international market of related fields.
Ian Askill, Ph.D.
Gary Pennington, MD
Specialty: Plastic Surgery
Daniela Höller Obrigkeit, MD
Specialty: Dermatology – Germany
Ananth Murthy, MD
Specialty: Pediatric Plastic Surgery